Towards a unified protocol for handling of CSF before β-amyloid measurements

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

(2018) Oskar Hansson et al.   Alzheimers & Dementia

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

(2018) Oskar Hansson et al.   Alzheimers & Dementia

Preanalytical Sample Handling and Sample Stability Testing for the Neurochemical Dementia Diagnostics

(2018) Rüdiger Zimmermann et al.   JOURNAL OF ALZHEIMERS DISEASE

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease

(2018) Leslie M. Shaw et al.   Alzheimers & Dementia

Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting

(2017) Christelle Gervaise-Henry et al.   JOURNAL OF ALZHEIMERS DISEASE

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)

(2017) Hugo Vanderstichele et al.   Alzheimers Research & Therapy

Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment

(2017) Shorena Janelidze et al.   JAMA Neurology

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid

(2016) Tobias Bittner et al.   Alzheimers & Dementia

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

(2016) Antoine Leuzy et al.   BRAIN

Performance Evaluation of an Automated ELISA System for Alzheimer’s Disease Detection in Clinical Routine

(2016) Davide Chiasserini et al.   JOURNAL OF ALZHEIMERS DISEASE

Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes

(2016) Hugo Marcel Johan Vanderstichele et al.   JOURNAL OF ALZHEIMERS DISEASE

Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer’s Disease with Updated Protocols

(2016) Min Jeong Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

(2016) Shorena Janelidze et al.   Annals of Clinical and Translational Neurology

Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid

(2015) N. Le Bastard et al.   CLINICAL CHEMISTRY

The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid

(2015) Jamie Toombs et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers

(2015) Maria João Leitão et al.   Frontiers in Neurology

Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid-  in Cerebrospinal Fluid

(2014) A. Leinenbach et al.   CLINICAL CHEMISTRY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?

(2014) William T. Hu et al.   Annals of Clinical and Translational Neurology

Identification of an important potential confound in CSF AD studies: aliquot volume

(2013) Jamie Toombs et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

(2013) Anja H. Simonsen et al.   JOURNAL OF NEUROSCIENCE METHODS

Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid

(2012) Valerie C. Cullen et al.   AAPS Journal

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system

(2012) Brit Mollenhauer et al.   JOURNAL OF NEURAL TRANSMISSION

A general and simple method for obtainingR2from generalized linear mixed-effects models

(2012) Shinichi Nakagawa et al.   Methods in Ecology and Evolution

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

The Effect of Preanalytical Factors on Stability of the Proteome and Selected Metabolites in Cerebrospinal Fluid (CSF)

(2009) Therese Rosenling et al.   JOURNAL OF PROTEOME RESEARCH